title: Is this critically ill patient immunocompromised?
authors.affiliation: Medical Intensive Care Unit, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. frederic.pene@cch.aphp.fr.|University Paris Descartes, Paris, France. frederic.pene@cch.aphp.fr.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Pène
authors.affiliation: Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
authors.forename: Peter
authors.initials: P
authors.lastname: Pickkers
authors.affiliation: Departments of Anesthesiology, Medicine, and Surgery, Washington University School of Medicine, 660 South Euclid, St Louis, MO, 63110, USA.
authors.forename: Richard S
authors.initials: RS
authors.lastname: Hotchkiss
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D003422:Critical Care; D016638:Critical Illness / Q000628:therapy; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology*; D007362:Intensive Care Units; D012128:Respiratory Distress Syndrome / Q000188:drug therapy / Q000276:immunology*; D018805:Sepsis / Q000188:drug therapy / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic